SE
Septerna Inc
SEPN · NASDAQ
$38.69 +0.68% (+$0.26)
1M -3.28%
Market Cap $1.78B
P/E Ratio -
Div. Yield -
ROE 6.31%
Piotroski F-Score Weak
3/9Valuation
53 /100
Fair P/S 18.01x
P/B 4.60x
P/FCF 16.94x
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
50 /100
Moderate Gross margin 99.57%
Net margin 24.51%
FCF margin 106.29%
Quality
2 /100
Poor ROIC 9.40%
ROE 6.31%
Asset turnover 0.17x
Debt
100 /100
Low Debt/Equity 0.06x
Current ratio 4.99x
Int. coverage N/A
Stability
1 /100
Unstable Beta 2.29x
EPS volatility 14,515.69%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na SEPN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeffrey T. Finer
Employees
123
Headquarters
South San Francisco
Nadcházející události
09 LIS
Earnings
Upcoming earnings report